ArticleCancer reports (Hoboken, N.J.)2025

Real-World Outcomes of Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma: Analyzing Patient-Specific Factors Influencing Survival and Response Rate.

Lena Huber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.